JP2009538898A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538898A5 JP2009538898A5 JP2009512684A JP2009512684A JP2009538898A5 JP 2009538898 A5 JP2009538898 A5 JP 2009538898A5 JP 2009512684 A JP2009512684 A JP 2009512684A JP 2009512684 A JP2009512684 A JP 2009512684A JP 2009538898 A5 JP2009538898 A5 JP 2009538898A5
- Authority
- JP
- Japan
- Prior art keywords
- progression
- diabetes
- delaying
- type
- gpr119 agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- AJJISMLYIMQAKP-OAHLLOKOSA-N 5-[4-[(2r)-4-(3-fluoro-4-methylsulfonylphenoxy)butan-2-yl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole Chemical compound CC(C)C1=NOC(N2CCC(CC2)[C@H](C)CCOC=2C=C(F)C(=CC=2)S(C)(=O)=O)=N1 AJJISMLYIMQAKP-OAHLLOKOSA-N 0.000 claims 4
- 229940100607 GPR119 agonist Drugs 0.000 claims 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 4
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003384 small molecules Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102100033839 Glucose-dependent insulinotropic receptor Human genes 0.000 description 1
- 101000996752 Homo sapiens Glucose-dependent insulinotropic receptor Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013293 zucker diabetic fatty rat Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0610746.0A GB0610746D0 (en) | 2006-06-01 | 2006-06-01 | Method of treatment |
| PCT/GB2007/050313 WO2007138362A1 (en) | 2006-06-01 | 2007-06-01 | Use of gpcr agonists to delay progression of diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009538898A JP2009538898A (ja) | 2009-11-12 |
| JP2009538898A5 true JP2009538898A5 (https=) | 2012-12-27 |
Family
ID=36694688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009512684A Pending JP2009538898A (ja) | 2006-06-01 | 2007-06-01 | 糖尿病の進行を遅らせるためのｇｐｃｒアゴニストの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090258816A1 (https=) |
| EP (1) | EP2029124A1 (https=) |
| JP (1) | JP2009538898A (https=) |
| GB (1) | GB0610746D0 (https=) |
| WO (1) | WO2007138362A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0817211A2 (pt) | 2007-09-20 | 2017-05-16 | Irm Llc | composto composições como moduladores da atividade de gpr119 |
| EP2108960A1 (en) | 2008-04-07 | 2009-10-14 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY |
| WO2010056907A2 (en) * | 2008-11-12 | 2010-05-20 | The Scripps Research Institute | Compounds that induce pancreatic beta-cell expansion |
| JP5378825B2 (ja) * | 2009-02-17 | 2013-12-25 | 出光興産株式会社 | Ｇｐｒ１１９アゴニスト |
| GB0904285D0 (en) | 2009-03-12 | 2009-04-22 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| GB0904284D0 (en) | 2009-03-12 | 2009-04-22 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| GB0904287D0 (en) | 2009-03-12 | 2009-04-22 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| AR077214A1 (es) * | 2009-06-24 | 2011-08-10 | Neurocrine Biosciences Inc | Heterociclos nitrogenados y composiciones farmaceuticas que los contienen |
| AU2010264720A1 (en) * | 2009-06-24 | 2011-12-08 | Boehringer Ingelheim International Gmbh | New compounds, pharmaceutical composition and methods relating thereto |
| EP2547339A1 (en) | 2010-03-18 | 2013-01-23 | Boehringer Ingelheim International GmbH | Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions |
| GB201006167D0 (en) | 2010-04-14 | 2010-05-26 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| GB201006166D0 (en) | 2010-04-14 | 2010-05-26 | Prosidion Ltd | Compounds for the treatment of metabolic disorders |
| WO2014187964A2 (en) * | 2013-05-23 | 2014-11-27 | University Of Bremen | Novel treatment of metabolic diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6100042A (en) * | 1993-03-31 | 2000-08-08 | Cadus Pharmaceutical Corporation | Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| JP4958560B2 (ja) * | 2003-12-24 | 2012-06-20 | プロシディオン・リミテッド | Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体 |
| US20090325924A1 (en) * | 2005-06-30 | 2009-12-31 | Stuart Edward | GPCR Agonists |
| US7638541B2 (en) * | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
-
2006
- 2006-06-01 GB GBGB0610746.0A patent/GB0610746D0/en not_active Ceased
-
2007
- 2007-06-01 US US12/303,028 patent/US20090258816A1/en not_active Abandoned
- 2007-06-01 JP JP2009512684A patent/JP2009538898A/ja active Pending
- 2007-06-01 WO PCT/GB2007/050313 patent/WO2007138362A1/en not_active Ceased
- 2007-06-01 EP EP07733734A patent/EP2029124A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009538898A5 (https=) | ||
| JP2007169302A5 (https=) | ||
| JP2006517944A5 (https=) | ||
| CL2007001992A1 (es) | Compuestos derivados de pirimidilciclopentanos; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodege | |
| CL2007002018A1 (es) | Compuestos derivados de isoxazolinas sustituidas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para el tratamiento de una enfermedad causada por un aumento en la proliferacion celular. | |
| SI1830855T1 (sl) | Trdne oralno aplikabilne farmacevtske dajalne oblike z modificiranim sproščanjem ki vsebujejo rivaroksaban | |
| CL2006002831A1 (es) | Compuestos derivados de sulfonamida: proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad mediada por el receptor de glucocorticoides. | |
| JP2009537554A5 (https=) | ||
| CL2007001993A1 (es) | Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat | |
| CL2007003583A1 (es) | Formulacion farmaceutica estable, parenteral, del anticuerpo contra el peptido beta amiloide (abeta); y uso de la formulacion para el tratamiento de la enfermedad de alzheimer. | |
| JP2007522094A5 (https=) | ||
| JP2006503588A5 (https=) | ||
| JP2011522816A5 (https=) | ||
| JP2008302206A5 (https=) | ||
| JP2012502037A5 (https=) | ||
| JP2007504174A5 (https=) | ||
| JP2007527914A5 (https=) | ||
| JP2003503454A5 (https=) | ||
| JP2009506117A5 (https=) | ||
| CL2007003192A1 (es) | Compuestos derivados de arilamidas sustituidas por tiazol u oxazol; composicion farmaceutica; y uso para el tratamiento de una enfermedad del tracto urinario. | |
| ZA200802873B (en) | Solid orally administerable pharmaceutical dosage forms with rapid active principle release | |
| NO20091501L (no) | Farmasoytiske sammensetninger | |
| JP2007536277A5 (https=) | ||
| JP2007520565A5 (https=) | ||
| ES2531516T3 (es) | Uso de escina |